A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients

Lung Cancer

Volumn 88, Issue 2, 2015, Pages 201-207

  Won, Young Woong ^a,b   Joo, Jungnam ^a   Yun, Tak ^a   Lee, Geon Kook ^a   Han, Ji Youn ^a   Kim, Heung Tae ^a   Lee, Jin Soo ^a   Kim, Moon Soo ^a   Lee, Jong Mog ^a   Lee, Hyun Sung ^a   Zo, Jae Ill ^a,c   Kim, Sohee ^a  

^a National Cancer Center   (South Korea)

^b Hanyang University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adenocarcinoma histology; Brain metastasis; Nomogram; Non small cell lung cancer; Relapse; TNM stage

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BRAIN HISTOLOGY; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADENOCARCINOMA; AGED; BRAIN; BRAIN TUMOR; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECURRENT DISEASE; SECONDARY; STATISTICAL MODEL; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOMOGRAMS; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84926418526     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.02.006     Document Type: Article

References (38)

1. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics 2011. CA Cancer J Clin 2011.
2. Ferlay J., Parkin D., Curado M., Bray F., Edwards B., Shin H. Cancer incidence in five continents, volumes I to IX: IARC CancerBase no. 9 [Internet] 2010, International Agency for Research on Cancer, Lyon (France), [in 2011].
3. Calman L., Beaver K., Hind D., Lorigan P., Roberts C., Lloyd-Jones M. Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis. J Thorac Oncol 1993, 2011:6.
4. Iasonos A., Schrag D., Raj G.V., Panageas K.S. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008, 26:1364-1370.
5. Goldstraw P., Crowley J.J. The International Association for the Study of Lung Cancer international staging project on lung cancer. J Thorac Oncol 2006, 1:281.
6. Harrell F., Lee K.L., Mark D.B. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
7. Harrell F.E., Califf R.M., Pryor D.B., Lee K.L., Rosati R.A. Evaluating the yield of medical tests. JAMA 1982, 247:2543-2546.
8. Pencina M.J., D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004, 23:2109-2123.
9. Royston P., Altman D.G. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol 2013, 13:33.
10. Douillard J.Y., Rosell R., De Lena M., Carpagnano F., Ramlau R., Gonzáles-Larriba J.L., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7:719-727.
11. Gilbert S., Reid K.R., Lam M.Y., Petsikas D. Who should follow up lung cancer patients after operation?. Ann Thorac Surg 2000, 69:1696-1700.
12. Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., Takai E., et al. The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease. J Thorac Cardiovasc Surg 1994, 108:680.
13. Figlin R.A., Piantadosi S., Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med 1988, 318:1300-1305.
14. Hubbs J.L., Boyd J.A., Hollis D., Chino J.P., Saynak M., Kelsey C.R. Factors associated with the development of brain metastases. Cancer 2010, 116:5038-5046.
15. Carolan H., Sun A.Y., Bezjak A., Yi Q.L., Payne D., Kane G., et al. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection. Lung Cancer 2005, 49:109-115.
16. Bajard A., Westeel V., Dubiez A., Jacoulet P., Pernet D., Dalphin J., et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 2004, 45:317-323.
17. Ceresoli G.L., Reni M., Chiesa G., Carretta A., Schipani S., Passoni P., et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 2002, 95:605.
18. Feld R., Rubinstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984, 2:1352-1358.
19. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129.
20. Wong S.L., Kattan M.W., McMasters K.M., Coit D.G. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on cancer staging system. Ann Surg Oncol 2005, 12:282-288.
21. Arriagada R., Auperin A., Burdett S., Higgins J., Johnson D., Le Chevalier T., et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010, 375:1267.
22. Aupérin A., Le Péchoux C., Rolland E., Curran W.J., Furuse K., Fournel P., et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010, 28:2181-2190.
23. Andre F., Grunenwald D., Pujol J.L., Girard P., Dujon A., Brouchet L., et al. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered. Cancer 2001, 91:2394-2400.
24. Gaspar L.E., Chansky K., Albain K.S., Vallieres E., Rusch V., Crowley J.J., et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol 2005, 23:2955-2961.
25. Strauss G.M., Herndon J.E., Sherman D.D., Mathisen D.J., Carey R.W., Choi N.C., et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992, 10:1237-1244.
26. Alexander III E., Moriarty T.M., Davis R.B., Wen P.Y., Fine H.A., Black P.M., et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995, 87:34-40.
27. Dimitropoulos C., Hillas G., Nikolakopoulou S., Kostara I., Sagris K., Vlastos F., et al. Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?. Cancer Manag Res 2011, 3:287.
28. Jacot W., Quantin X., Boher J., Andre F., Moreau L., Gainet M., et al. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer 2001, 84:903.
29. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
30. Aupérin A., Arriagada R., Pignon J.P., Le Péchoux C., Gregor A., Stephens R.J., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999, 341:476-484.
31. Meert A.P., Paesmans M., Berghmans T., Martin B., Mascaux C., Vallot F., et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001, 1:5.
32. Gore E.M., Bae K., Wong S.J., Sun A., Bonner J.A., Schild S.E., et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of Radiation Therapy Oncology Group Study RTOG 0214. J Clin Oncol 2011, 29:272-278.
33. Lester J.F., MacBeth F.R., Coles B. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane review. Int J Radiat Oncol Biol Phys 2005, 63:690-694.
34. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 68:1388-1395.
35. Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004, 22:157-165.
36. Yokoi K., Miyazawa N., Arai T. Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography. Ann Thorac Surg 1996, 61:546-550. [discussion 551].
37. Nishikawa T., Ueba T., Kawashima M., Kajiwara M., Iwata R., Kato M., et al. Early detection of metachronous brain metastases by biannual brain MRI follow-up may provide patients with non-small cell lung cancer with more opportunities to have radiosurgery. Clin Neurol Neurosurg 2010, 112:770-774.
38. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706.